Lotus Pharmaceutical Co., Ltd. (TPE:1795)

Redfin Revenue

Lotus Pharmaceutical had revenue of 4.73B TWD in the quarter ending March 31, 2025, with 12.66% growth. This brings the company's revenue in the last twelve months to 19.12B, up 14.93% year-over-year. In the year 2024, Lotus Pharmaceutical had annual revenue of 18.58B with 9.59% growth.

• Revenue (ttm): 19.12B
• Revenue Growth: +14.93%
• P/S Ratio: 2.96
• Revenue / Employee: 17.39M
• Employees: 1,099
• Market Cap: 56.54B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	18.58B	1.63B	9.59%
Dec 31, 2023	16.96B	2.33B	15.89%
Dec 31, 2022	14.63B	1.98B	15.68%
Dec 31, 2021	12.65B	1.92B	17.90%
Dec 31, 2020	10.73B	1.12B	11.63%